Intravitreally injected ranibizumab versus photodynamic therapy for CNV secondary to choroidal osteoma: a 7-year follow-up case report

• Li-Yuan Rong,
• Li Ran,
• Shi-Ying Li,
• Xiao-Hong Meng,
• Yan-Ling Long,
• Hai-Wei Xu

Affiliations

Li-Yuan Rong

Shi-Ying Li. Department of Ophthalmology, Xiang'an Hospital of Xiamen University; Medical Center of Xiamen University; School of Medicine, Xiamen University, Xiamen 361102, Fujian Province, China. [email protected]

Li Ran

Southwest Hospital, Southwest Eye Hospital, the Third Military Medical University (Army Medical University), Chongqing 400038, China

Shi-Ying Li

Southwest Hospital, Southwest Eye Hospital, the Third Military Medical University (Army Medical University), Chongqing 400038, China; Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing 400038, China; Department of Ophthalmology, Xiang'an Hospital of Xiamen University; Medical Center of Xiamen University

Xiao-Hong Meng

Southwest Hospital, Southwest Eye Hospital, the Third Military Medical University (Army Medical University), Chongqing 400038, China; Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing 400038, China

Yan-Ling Long

Southwest Hospital, Southwest Eye Hospital, the Third Military Medical University (Army Medical University), Chongqing 400038, China; Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing 400038, China

Hai-Wei Xu

Southwest Hospital, Southwest Eye Hospital, the Third Military Medical University (Army Medical University), Chongqing 400038, China; Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing 400038, China